Final results of a phase 2 clinical trial of LCL161, an oral SMAC mimetic for patients with myelofibrosis
- Resource Type
- Article
- Authors
- Pemmaraju, Naveen ; Carter, Bing Z.; Bose, Prithviraj; Jain, Nitin; Kadia, Tapan M.; Garcia-Manero, Guillermo; Bueso-Ramos, Carlos E.; DiNardo, Courtney D.; Bledsoe, Sharon; Daver, Naval G.; Popat, Uday; Konopleva, Marina Y.; Zhou, Lingsha; Pierce, Sherry; Estrov, Zeev E.; Borthakur, Gautam M.; Ohanian, Maro; Qiao, Wei; Masarova, Lucia; Wang, Xuemei; Mak, Po Yee; Cortes, Jorge; Jabbour, Elias; Verstovsek, Srdan
- Source
- In Blood Advances 24 August 2021 5(16):3163-3173
- Subject
- Language
- ISSN
- 2473-9529